Congo will start using Ebola vaccine manufactured by Merck as early as next week. Four people tested positive for Ebola in and around Mangina, a town in North Kivu province. Another 20 people died from unidentified hemorrhagic fevers in July.
More articles on clinical leadership and infection control:
Denver Greyhound bus quarantined after suspected Ebola case
No Ebola for Denver Health patient
Harboring multidrug-resistant gram-negative bacteria ups likelihood of subsequent infections
